Chronic obstructive pulmonary disease (COPD) is a long-term condition that causes breathing difficulties and frequent flare-ups. COPD with eosinophilic phenotype occurs when elevated eosinophils (immune cells linked to inflammation) are present in the blood, airways, or both. This subtype often leads to more frequent and severe exacerbations. However, it may respond more effectively to anti-inflammatory treatments like inhaled corticosteroids.
Managing COPD with eosinophilic phenotype can be challenging, but ongoing research is helping uncover new possibilities. Clinical Trials for COPD provide opportunities to explore treatments that may offer better symptom management and improved quality of life.
